BioVaxys Technology Corp.

CNSX:BIOV Stock Report

Market Cap: CA$15.8m

BioVaxys Technology Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

CNSX:BIOV Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
26 Jan 24BuyCA$19,000Kenneth KovanIndividual633,333CA$0.03
14 Jul 23BuyCA$6,038Kenneth KovanIndividual250,000CA$0.025

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of BIOV?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders28,776,26213.7%
General Public182,036,89986.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 45.3%.


Top Shareholders

Top 4 shareholders own 13.65% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.67%
James Passin
16,177,333CA$1.2m18.3%no data
3.49%
Kenneth Kovan
7,352,862CA$551.5k9.43%no data
2.37%
David Berd
4,996,067CA$374.7k0%no data
0.12%
Anthony John Dutton
250,000CA$18.8k0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.